News

Novo Nordisk to lower list price, or wholesale acquisition cost, for Wegovy and Ozempic

Feb 24, 2026 | News, Healthcare

The reduction in price to $675 will take effect at the beginning of next year

Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo

Feb 24, 2026 | News, Regulatory

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026

Feb 23, 2026 | News, Marketing

The conference will take place from 6 to 7 October 2026 in Copenhagen, Denmark

Gilead to acquire Arcellx in deal worth $7.8bn

Feb 23, 2026 | News, Healthcare

The US FDA has accepted a licence application for drug for relapsed/refractory multiple myeloma

PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

Feb 20, 2026 | News, Regulatory

Rare diseases are defined as conditions affecting fewer than 200,000 people in the US or fewer than five in 10,000 individuals in the European Union

CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek

Feb 20, 2026 | News, Research

The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies

Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input

Feb 19, 2026 | News, Regulatory

While a lack of meal announcements can lead to lower glycaemic control, it reduces the mental burden for those with type 1 diabetes

British Chambers of Commerce partners with Singapore to scale up UK imports

Feb 18, 2026 | News, Marketing

The Singapore Life Sciences Trade Accelerator six-month pilot programme aims to increase export opportunities

UCB’s Kygevvi receives positive CHMP opinion for thymidine kinase 2 deficiency

Feb 17, 2026 | News, Regulatory

TK2d is an extremely rare disease characterised by severe and progressive muscle weakness

Study shows infants given RSV vaccination benefit beyond first RSV season

Feb 16, 2026 | News, Research

The RSV virus is highly contagious and can cause serious respiratory illness for infants

LEO Pharma’s Anzupgo cream progresses to phase 3 trial for lichen sclerosus

Feb 11, 2026 | News, Research

There are currently no approved treatments specifically indicated for LS in the US or Europe

Novo Nordisk announces positive results for CagriSema in type 2 diabetes

Feb 10, 2026 | News, Research

CagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses

Novo Nordisk to lower list price, or wholesale acquisition cost, for Wegovy and Ozempic

Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo

Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026

Gilead to acquire Arcellx in deal worth $7.8bn

PureTech’s deupirfenidone gets FDA and EC Orphan Drug Designations for idiopathic pulmonary fibrosis

CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek

Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input

British Chambers of Commerce partners with Singapore to scale up UK imports

UCB’s Kygevvi receives positive CHMP opinion for thymidine kinase 2 deficiency

Study shows infants given RSV vaccination benefit beyond first RSV season

LEO Pharma’s Anzupgo cream progresses to phase 3 trial for lichen sclerosus

Novo Nordisk announces positive results for CagriSema in type 2 diabetes

Latest content

Latest intelligence

Quick links